{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:08:33Z","timestamp":1793452113393,"version":"4.5.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1001\/jamacardio.2017.2289","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T12:30:59Z","timestamp":1501677059000},"page":"959","source":"Crossref","is-referenced-by-count":144,"title":["Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease"],"prefix":"10.1001","volume":"2","author":[{"given":"Christopher P.","family":"Cannon","sequence":"first","affiliation":[{"name":"Baim Institute for Clinical Research, Boston, Massachusetts2Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Khan","sequence":"additional","affiliation":[{"name":"Global Health Economics and Outcomes Research, Sanofi, Bridgewater, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa C.","family":"Klimchak","sequence":"additional","affiliation":[{"name":"Axtria, Berkeley Heights, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research, Boston, Massachusetts5Department of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sasiela","sequence":"additional","affiliation":[{"name":"Program Direction, Cardiovascular and Metabolism, Regeneron Pharmaceuticals, Inc, Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.2289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T12:31:13Z","timestamp":1505910673000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.2289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2017.2289","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}